Hugues Corbeil
Keine laufenden Positionen mehr
Profil
Dr. Hugues Corbeil is Director-Finance & Operations of PainCeptor since March 2004.
Before joining the Company, he was at T2C2/Bio, a Montreal-based venture capital fund making investments in the biotechnology and biopharmaceutical sector.
He received his Ph.D.
in Biochemistry from McGill University.
He also holds a MBA from the University of Montreal's École des Hautes Études Commerciales (HEC) and is a CFA charter holder.
Moreover, he is a member of the Association for Investment Management and Research and the Licensing Executives Society.
Ehemalige bekannte Positionen von Hugues Corbeil
| Unternehmen | Position | Ende |
|---|---|---|
PainCeptor Pharma Corp.
 PainCeptor Pharma Corp. Pharmaceuticals: MajorHealth Technology PainCeptor Pharma Corp. operates as a biopharmaceutical company which engages in the development of pharmaceuticals for chronic and acute pain. It offers next generation therapeutic drugs for the treatment of chronic and acute pain. The firms products includes NGF/p75-TrkA, ASIC1a and ASIC3. The company was founded by Louis Lamontagne in 2003 and is headquartered in St-Laurent, Canada. | Finanzdirektor/CFO | - |
Ausbildung von Hugues Corbeil
| McGill University | Doctorate Degree |
| University of Montréal | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
PainCeptor Pharma Corp.
PainCeptor Pharma Corp. Pharmaceuticals: MajorHealth Technology PainCeptor Pharma Corp. operates as a biopharmaceutical company which engages in the development of pharmaceuticals for chronic and acute pain. It offers next generation therapeutic drugs for the treatment of chronic and acute pain. The firms products includes NGF/p75-TrkA, ASIC1a and ASIC3. The company was founded by Louis Lamontagne in 2003 and is headquartered in St-Laurent, Canada. | Health Technology |
